Application of Metabolomics for Translational and Biological Research (R21)

Brief Description:
The purpose of this Funding Opportunity Announcement (FOA), sponsored by multiple NIH Institutes/Centers (ICs), is to promote the use of metabolomic technologies in translational research in human health and disease for the purposes of enabling and improving disease detection, diagnosis, risk assessment, prognosis, and prediction of therapeutic responses. In addition to this overall goal, specific scopes and objectives of the participating ICs are presented below. Since this FOA uses the R21 funding mechanism, studies proposed are intended to be exploratory and may not achieve the status of complete validation.

Read more about this funding opportunity here